Back to results
US 6,552,225 B1Granted
Chemical compounds
AssigneeAstraZeneca AB
InventorsRoger John Butlin, Janet Elizabeth Pease, Michael Howard Block, Thorsten Nowak, Jeremy Nicholas Burrows
Life of this patent
Estimating the term…
Abstract
A compound of formula (I) wherein: R1, R2, R3, R4, R5, R6 and R7 are as defined within; or a pharmaceutically acceptable salt or an in vivo hydrolysable ester thereof is described. The use of compounds of formula (I) in the production of an elevation of PDH activity in a warm-blooded animal such as a human being are also described. Pharmaceutical compositions, methods and processes for preparation of compounds of formula (I) are detailed.
Claims13
A compound of formula (I):
- wherein:
- R1 and R2 are each selected independently from hydrogen, phenyl optionally substituted by one or more Q, naphthyl optionally substituted by one or more Q, C3-6cycloalkyl optionally substituted by one or more Q, C2-6alkenyl, C2-6alkynyl, C1-6alkyl optionally substituted by one or more Q, R8T—, R9C1-6alkylT— and a heterocyclic group optionally substituted on a ring carbon by one or more Q and wherein if said heterocyclic group contains an —NH— moiety that nitrogen may be optionally substituted by a group selected from D,
- or R1 and R2 together with the nitrogen atom to which they are attached form a group Het which is optionally substituted on a ring carbon by one or more Q and wherein if group Het contains an —NH— moiety that nitrogen may be optionally substituted by a group selected from D;
- R3 and R4 are independently Ckalkyl optionally substituted by 1 to 2k+1 atoms selected from fluoro and chloro wherein k is 1-3;
- or R3 and R4 together with the carbon atom to which they are attached, form a Cmcycloalkyl ring optionally substituted by 1 to 2m-2 fluorine atoms wherein m is 3-5;
- R5 is hydrogen, C1-6alkyl, haloC1-6alkyl, C1-6alkoxy, haloC1-6alkoxy, cyano, nitro, C2-6alkenyloxy, trifluoromethylthio, halo, hydroxy, amino, N—(C1-6alkyl)amino, N—(C1-6alkyl)2amino, C1-6alkanoylamino, C1-6alkanoyl(N—C1-6alkyl)amino, C1-6alkylsulphonylamino, C1-6alkylsulphonyl(N—C1-6alkyl)amino, thiol, C1-6alkylsulphanyl, C1-6alkylsulphinyl, C1-6alkylsulphonyl, sulphamoyl, N—(C1-6alkyl)aminosulphonyl, N—(C1-6alkyl)2aminosulphonyl, carboxy, carbamoyl, N—(C1-6alkyl)carbamoyl, N—(C1-6alkyl)2carbamoyl, C1-6alkoxycarbonyl, formyl, C1-6alkanoyl, C1-6alkanoyloxy, C2-6alkenyl or C2-6alkynyl;
- R6 is hydrogen or Q;
- R7 is hydrogen, trifluoromethyl, C1-4alkyl, halo, hydroxy, trifluoromethoxy, cyano, C1-4alkoxy, formyl, C1-4alkanoyl, C1-4alkanoyloxy, amino, N—(C1-4alkyl)amino, N—(C1-4alkyl)2amino, C1-4alkanoylamino, C1-4alkanoyl(N—C1-4alkyl)amino, nitro, carboxy, carbamoyl, ureido, C1-4alkoxycarbonyl, thiol, C1-4alkylsulphanyl, C1-4alkylsulphinyl, C1-4alkylsulphonyl, sulphamoyl, N—(C1-4alkyl)aminosulphonyl, N—(C1-4alkyl)2aminosulphonyl, N′—(C1-4alkyl)ureido or N′—(C1-4alkyl)2ureido;
- R8 is C1-6alkyl optionally substituted by one or more R10, C3-6cycloalkyl optionally substituted by one or more R10, phenyl optionally substituted by one or more R10, naphthyl optionally substituted by one or more R10 or a heterocyclic group optionally substituted on a ring carbon by one or more R10 and if said heterocyclic group contains an —NH— moiety that nitrogen may be optionally substituted by a group selected from D;
- R9 is phenyl optionally substituted by one or more R10, naphthyl optionally substituted by one or more R10 or a heterocyclic group optionally substituted on a ring carbon by one or more R10 and if said heterocyclic group contains an —NH— moiety that nitrogen may be optionally substituted by a group selected from D;
- R10 is C1-6alkyl-M— optionally substituted by R16, halo, hydroxy, cyano, formyl, amino, nitro, carboxy, carbamoyl, thiol, sulphamoyl, phenyl optionally substituted by R16, a heterocyclic group optionally substituted on a ring carbon by R16 wherein if said heterocyclic group contains an —NH— moiety that nitrogen may be optionally substituted by a group selected from D;
- Q is C1-6alkyl-M— optionally substituted with one or more R11, C2-6alkenyl-M— optionally substituted by one or more R11, C2-6alkynyl-M— optionally substituted by one or more R11, R13—M—, hydroxy, halo, cyano, thiol, sulphamoyl, nitro, carboxy, amino, carbamoyl, formyl or ureido;
- T is —O—, —C(O)—, —NH—,—N(N—C1-6alkyl)-, —C(O)NH—, —NHC(O)—, —C(O)N(N—C1-6alkyl)—, —N(N—C1-6alkyl)C(O)—, —SO2—, —C(S)—, —C(S)NH—, —NHC(S)—, —C(S)N(N—C1-6alkyl)- or —N(N—C1-6alkyl)C(S)—;
- M is —(O—, —N(R14)—, —C(O)—, —N(R14)C(O)—, —C(O)N(R14)—, —S(O)n— wherein n is 0-2, —OC(O)—,—C(O)O—, —N(R14)C(O)O—, —OC(O)N(R14), —C(S)N(R14)—, —N(R14)C(S)—, —SO2N(R14)—, —N(R14)SO2—, —N(R14)C(O)N(R14)—, —N(R14)C(S)N(R14)—, —SO2NHC(O)—, —SO2N(R14)C(O)—, —C(O)NHSO2—, —C(O)N(R14)SO2— or M is a direct bond;
- D is C1-6alkyl, C1-6alkanoyl, C1-6alkylsulphonyl, C1-6alkoxycarbonyl, carbamoyl, N—(C1-6alkyl)carbamoyl, N—(C1-6alkyl)2carbamoyl, benzoyl, (heterocyclic group)carbonyl, phenylsulphonyl, (heterocyclic group)sulphonyl, phenyl or a carbon linked heterocyclic group, and wherein any C1-6alkyl group may be optionally substituted by one or more R11, and wherein any phenyl or heterocyclic group may be optionally substituted on a ring carbon by one or more groups selected from R10 and if a heterocyclic group contains an —NH— moiety that nitrogen may be optionally substituted by a group selected from E;
- E is C1-6alkyl, C1-6alkanoyl, C1-6alkylsulphonyl, C1-6alkoxycarbonyl, carbamoyl, N—(C1-6alkyl)carbamoyl, N—(C1-6alkyl)2carbamoyl, C1-6alkoxyC1-6alkanoyl, phenylC1-6alkyl, benzoyl, phenylC1-6alkanoyl, phenylC1-6alkoxycarbonyl or phenylsulphonyl.
- R11 is hydroxy, nitro, cyano, thiol, halo, ureido, amino, N—(C1-6alkyl)amino, N—(C1-6alkyl)2amino, carboxy, C1-6alkoxy, carbamoyl, N—(C1-6alkyl)carbamoyl, N—(C1-6alkyl)2carbamoyl, formyl, sulphamoyl, N—C1-6alkylaminosulphonyl, N—(C1-6alkyl)2aminosulphonyl, C1-6alkylsulphonylamino, C1-6alkanoylamino, C1-6alkylsulphanyl, C1-6alkylsulphinyl, C1-6alkylsulphonyl, phenyl optionally substituted by one or more R10, naphthyl optionally substituted by one or more R10, or a heterocyclic group optionally substituted on a ring carbon by one or more R10 , and if said heterocyclic group contains an —NH— moiety that nitrogen may be optionally substituted by a group selected from D;
- R13 is phenyl optionally substituted by one or more R10, C3-6cycloalkyl optionally substituted by one or more R10, naphthyl optionally substituted by one or more R10, or a heterocyclic group optionally substituted on a ring carbon by one or more R10 and if said heterocyclic group contains an —NH— moiety that nitrogen may be optionally substituted by a group selected from D;
- R14 is hydrogen or C1-6alkyl optionally substituted by one or more R15 with the proviso that R15 is not a substituent on the carbon attached to the nitrogen atom of M;
- R15 is halo, hydroxy, amino, cyano, nitro, trifluoromethyl, trifluoromethoxy, C1-6alkyl, C2-6alkenyl, C2-6alkynyl, N—(C1-6alkyl)amino, N—(C1-6alkyl)2amino, C1-6alkanoylamino, C1-6alkanoyl(N—C1-6alkyl)amino, C1-6alkylsulphonylamino, C1-6alkylsulphonyl(N—C1-6alkyl)amino, thio, C1-6alkylsulphanyl, C1-6alkylsuphinyl, C1-6alkylsulphonyl, sulphamoyl, N—(C1-6alkyl)aminosulphonyl, N—(C1-6alkyl)2aminosulphonyl, carboxy, carbamoyl, N—(C1-6alkyl)carbamoyl, N—(C1-6alkyl)2carbamoyl, C1-6alkoxycarbonyl, C1-6alkanoyl or formyl;
- R6 is hydroxy, halo, cyano, C1-6alkoxy, formyl, C1-6alkanoyl, C1-6alkanoyloxy, amino, N—(C1-6alkyl)amino, N—(C1-6alkyl)2amino, C1-6alkanoylamino, C1-6alkanoyl(N—C1-6alkyl)amino, carboxy, carbamoyl, C1-6alkoxycarbonyl, C1-6alkylsulphanyl, C1-6alkylsulphinyl, C1-6alkylsulphonyl, sulphamoyl, N—(C1-6alkyl)aminosulphonyl or N—(C1-6alkyl)2aminosulphonyl;
- and wherein if one of R5, R6 and R7 is hydrogen the others cannot be hydrogen;
- or a pharmaceutically acceptable salt or an in vivo hydrolysable ester thereof.
20 more elements
A compound of formula (I) selected from:
- (R)-N-[2,3-dichloro-4-(methylaminosulphonyl)phenyl]-3,3,3-trifluoro-2-hydroxy-2-methylpropanamide;
- (R)-N-{2,3-dichloro-4-[(1-methyl-2-hydroxyethylamino)sulphonyl]phenyl}-3,3,3-trifluoro-2-hydroxy-2-methylpropanamide;
- (R)-N-[2-chloro-3-methyl-4-((S)-2-hydroxypropylamino-sulphonyl)phenyl]-3,3,3-trifluoro-2-hydroxy-2-methylpropanamide;
- (R)-N-[2-chloro-3-methyl-4-((R,S)-2-hydroxypropylaminosulphonyl)phenyl]-3,3,3-trifluoro-2-hydroxy-2-methylpropanamide;
- (R)-N-{2-chloro-3-methyl-4-[(3-hydroxyprop-2-ylamino)sulphonyl]phenyl}-3,3,3-trifluoro-2-hydroxy-2-methylpropanamide;
- (R)-N-[2,3-dichloro-4-((S)-3-hydroxyprop-2-ylamino-sulphonyl)phenyl]-3,3,3-trifluoro-2-hydroxy-2-methylpropanamide;
- (R)-N-[2-chloro-3-methyl-4-((S)-2-hydroxypropylamino-sulphonyl)phenyl]-3,3,3-trifluoro-2-hydroxy-2-methylpropanamide;
- (R)-N-[2-chloro-3-methyl-4-((R)-2-hydroxypropylamiio-sulphonyl)phenyl]-3,3,3-trifluoro-2-hydroxy-2-methylpropanamide;
- or a pharmaceutically acceptable salt or an in vivo hydrolysable ester thereof.
6 more elements
Dependencies are inferred from the claim text.